KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calumet (CLMT) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Calumet (CLMT) over the last 4 years, with Q3 2025 value amounting to $3.2 billion.

  • Calumet's Total Liabilities rose 381.19% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 381.19%. This contributed to the annual value of $3.2 billion for FY2024, which is 762.68% up from last year.
  • Latest data reveals that Calumet reported Total Liabilities of $3.2 billion as of Q3 2025, which was up 381.19% from $3.5 billion recorded in Q2 2025.
  • In the past 5 years, Calumet's Total Liabilities registered a high of $3.5 billion during Q2 2025, and its lowest value of $443.2 million during Q3 2023.
  • In the last 4 years, Calumet's Total Liabilities had a median value of $3.0 billion in 2023 and averaged $2.2 billion.
  • In the last 5 years, Calumet's Total Liabilities soared by 59194.49% in 2024 and then skyrocketed by 381.19% in 2025.
  • Calumet's Total Liabilities (Quarter) stood at $533.3 million in 2022, then surged by 461.79% to $3.0 billion in 2023, then increased by 7.63% to $3.2 billion in 2024, then fell by 1.27% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q3 2025, $3.5 billion for Q2 2025, and $3.4 billion during Q1 2025.